New approach to assess changes in brain activation during real walking using EEG
Objective: To examine the use of EEG during the performance of two well-known paradigms, dual task and oddball, to reveal changes in brain activation during…Neuroinflammation Predicts Dompaminergic Deficit in Early Parkinson Disease: DAT SPECT Imaging Study
Objective: We aimed to investigate whether striatal Dopamine transporter (DaT) uptake could be predicted by Neutrophil to lymphocyte ratio (NLR) or measures of disease severity…Relation of asymmetry of dopamine depletion with motor or non-motor symptoms in patients with Parkinson’s disease: A pilot study
Objective: This study was aimed to investigate whether asymmetry of dopamine depletion through dopamine transporter (DAT) imaging is associated with motor or non-motor symptoms in…Assessing working memory dysfunction with letter n-back functional MRI task in early-stage Parkinson’s disease
Objective: To assess the dynamic brain responses during a working memory n-back fMRI task in an early-stage PD cohort with variable mild cognitive impairment Background:…Remote patient monitoring with a digital biomarker approach generates clinically distinctive and meaningful sensor feature data in Parkinson’s disease: Differential relationships with MDS-UPDRS-III, PDQ-39 and DaT-SPECT
Objective: To determine whether sensor features derived from remote smartphone testing in Parkinson’s disease (PD) predicted clinical, quality of life and biomarker measures collected in…Longitudinal MRI to predict cognitive impairment in Parkinson’s disease
Objective: To determine the value of MRI metrics in predicting global cognitive ability in Parkinson’s disease (PD). Background: Progressive cognitive impairment is a dominant feature…The study of 18F-FDG PET / CT imaging in the value on Parkinson’s disease
Objective: In this study,we were to investigate imaging characteristics of 18F-FDG PET/CT in patients with Parkinson's disease (PD), and explore its value on PD. Background:…Predictors and biomarkers of pain in newly diagnosed Parkinson’s disease patients during a two-year follow-up
Objective: To identify clinical characteristics, predictors and biomarkers of pain at baseline and after a two-year follow-up period in newly diagnosed drug-naïve Parkinson's Disease (PD)…Effect of bedtime levodopa/carpidopa/entacapone (Stalevo®) on sleep disturbance in patients with Parkinson’s disease with motor fluctuation
Objective: To investigate the efficacy of levodopa/carbidopa/entacapone (Stalevo®) at bedtime on sleep disturbance in patients with Parkinson’s disease (PD) who have motor fluctuation. Background: Sleep…Early stage Parkinson’s disease phenotypes
Objective: Identify Parkinson’s disease (PD) subpopulation clusters present at disease onset using a number of motor and non-motor phenotypes. Background: PD is considered a syndrome,…
- « Previous Page
- 1
- …
- 140
- 141
- 142
- 143
- 144
- …
- 177
- Next Page »